Stamos Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.5M | Sell |
170,384
-16,421
| -9% | -$1.9M | 3.2% | 2 |
|
|
2025
Q4 | $19.7M | Sell |
186,805
-13,254
| -7% | -$1.24M | 3.16% | 2 |
|
|
2025
Q3 | $16.8M | Sell |
200,059
-26,846
| -12% | -$2.21M | 3.17% | 3 |
|
|
2025
Q2 | $18M | Buy |
226,905
+112,671
| +99% | +$8.96M | 3.22% | 2 |
|
|
2025
Q1 | $10.3M | Sell |
114,234
-9,446
| -8% | -$882K | 2.68% | 2 |
|
|
2024
Q4 | $12.3M | Buy |
123,680
+29,500
| +31% | +$3.04M | 2.89% | 6 |
|
|
2024
Q3 | $10.7M | Buy |
94,180
+24,190
| +35% | +$2.87M | 2.52% | 6 |
|
|
2024
Q2 | $8.66M | Sell |
69,990
-2,150
| -3% | -$277K | 1.84% | 7 |
|
|
2024
Q1 | $9.52M | Sell |
72,140
-13,860
| -16% | -$1.71M | 2.16% | 7 |
|
|
2023
Q4 | $9.38M | Sell |
86,000
-500
| -0.6% | -$51.9K | 2.54% | 7 |
|
|
2023
Q3 | $8.91M | Buy |
86,500
+12,290
| +17% | +$1.32M | 1.98% | 10 |
|
|
2023
Q2 | $8.56M | Sell |
74,210
-2,000
| -3% | -$227K | 2% | 11 |
|
|
2023
Q1 | $8.11M | Buy |
76,210
+15,910
| +26% | +$1.72M | 2.09% | 10 |
|
|
2022
Q4 | $6.69M | Sell |
60,300
-37,830
| -39% | -$3.87M | 2.12% | 12 |
|
|
2022
Q3 | $8.45M | Buy |
98,130
+5,830
| +6% | +$520K | 2.15% | 13 |
|
|
2022
Q2 | $8.41M | Hold |
92,300
| – | – | 2.54% | 14 |
|
|
2022
Q1 | $7.57M | Buy |
92,300
+1,500
| +2% | +$118K | 2.53% | 15 |
|
|
2021
Q4 | $6.96M | Buy |
90,800
+26,050
| +40% | +$2.07M | 3.23% | 11 |
|
|
2021
Q3 | $4.86M | Hold |
64,750
| – | – | 2.72% | 13 |
|
|
2021
Q2 | $5.04M | Buy |
64,750
+1,556
| +2% | +$116K | 2.65% | 15 |
|
|
2021
Q1 | $4.65M | Hold |
63,194
| – | – | 2.35% | 20 |
|
|
2020
Q4 | $4.93M | Buy |
63,194
+31,754
| +101% | +$2.43M | 2.1% | 15 |
|
|
2020
Q3 | $2.49M | Hold |
31,440
| – | – | 0.92% | 28 |
|
|
2020
Q2 | $2.32M | Sell |
31,440
-23,172
| -42% | -$1.74M | 1.33% | 18 |
|
|
2020
Q1 | $4.01M | Buy |
54,612
+20,091
| +58% | +$1.58M | 2.11% | 14 |
|
|
2019
Q4 | $3M | Sell |
34,521
-7,923
| -19% | -$651K | 2.42% | 10 |
|
|
2019
Q3 | $3.41M | Buy |
42,444
+17,502
| +70% | +$1.4M | 3.03% | 6 |
|
|
2019
Q2 | $2.02M | Sell |
24,942
-4,402
| -15% | -$337K | 2.02% | 11 |
|
|
2019
Q1 | $2.29M | Sell |
29,344
-7,336
| -20% | -$549K | 2.93% | 11 |
|
|
2018
Q4 | $2.67M | Buy |
+36,680
| New | +$2.59M | 2.02% | 17 |
|
Other funds holding MRK
VCM
VPM
Stamos Capital Partners's MRK Position: Q1 2026 in Review
Stamos Capital Partners reduced its Merck (MRK) stake by 8.8% in Q1 2026, selling an estimated $1.9M and leaving 170,384 shares worth $20.5M. The position accounts for 3.2% of the portfolio, ranked #2.
Stamos Capital Partners first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Stamos Capital Partners held 170,384 shares of Merck worth $20.5M as of Q1 2026.
- Stamos Capital Partners sold 16,421 Merck shares in Q1 2026, an estimated $1.9M.
- Merck made up 3.2% of Stamos Capital Partners's portfolio in Q1 2026, its #2 holding.
- Stamos Capital Partners first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.